Ciulla Thomas has filed 6 insider transactions across 2 companies since June 2022.
Most recent transaction: a grant/award of 50000 shares of Viridian Therapeutics, Inc.\DE ($VRDN) on February 05, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2024 | Viridian Therapeutics, Inc.\DE | $VRDN | Ciulla Thomas | Chief Medical Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 20, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Ciulla Thomas | Chief Medical Officer | S | Common Stock | 13700 | $1.47 | 291,890.0000 | 0 | 4.48% | 0.00% |
| Jan. 10, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Ciulla Thomas | Chief Medical Officer | S | Common Stock | 2170 | $1.62 | 305,590.0000 | 0 | 0.71% | 0.00% |
| June 30, 2022 | Clearside Biomedical, Inc. | $CLSDQ | Ciulla Thomas | Chief Medical Officer | A | Common Stock | 5000 | $1.25 | 302,760.0000 | 0 | 1.68% | 0.00% |
| Dec. 31, 2022 | Clearside Biomedical, Inc. | $CLSDQ | Ciulla Thomas | Chief Medical Officer | A | Common Stock | 5000 | $0.95 | 307,760.0000 | 0 | 1.65% | 0.00% |
| Jan. 4, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Ciulla Thomas | Chief Medical Officer | A | Employee Stock Option (right to buy) | 187500 | $0.00 | 187,500.0000 | 0 | 9999.99% | 0.00% |